Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Live webinar: Optimise your digital assets with UX research
- Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST
Research Partnership
- Rare diseases and orphan drugs: Our experience and expertise
Research Partnership
- Conducting research for publication video
Research Partnership
- Conference research case study
- How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
- Portfolio analysis: Using market research to master communications across a therapeutic category
Research Partnership
- EphMRA round up 2018
- EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership
- About us
- Contact us
- How to advertise
- Site map
- All content copyright © PMGroup Worldwide Ltd 2018
